Chronic hepatitis F4
Chronic hepatitis F4: Chronic hepatitis or cirrhosis, pleuritis or pulmonary abscess, gastritis, pneumonia or liver diseases.


1. Liver cirrhosis: 72 chronic hepatitis with liver cirrhosis and liver function damages took F4 or its modification for two months and 41 liver function resume to normal (56.94 percent), 29 improved (40.27 percent) and two did not complete the treatment.
2. TB related pleuritis: 8 patients with pleural fluid retention took F4 with other herbal formula found four were complete recovered, two improved and two did not.
3. Exudative pleuritis: 22 patients took F4 or its modification and western medicine together for a month and 13 cured (59.09 percent), 17 significantly improved (77.27 percent) and two did not improve (9.09 percent).
4. Pediatric pneumonia: Of 50 pediatric pneumonia patients taking F4 and other herbal formula found 37 were cured (74 percent), seven improved (14 percent) while six did not improve after the treatment (12 percent).
5. Silicosis: 33 patients took F4 along with other herb formula for two months and 28 significantly improved (78.78 percent), three improved (9.09 percent) and two did not improve (6.06 percent).
6. Stomach ache or gastritis: 176 patients took F4 or its modification for up to a month to treat various stomach problems --acute and chronic gastritis, ulcer or stomach ache-- and 90 were cured (51.13 percent), 71 improved (40.34 percent) and 15 did not improve (8.52 percent). 


Toxicity and side effects: There are no known side effects or toxicity of F4.
A bottle of Chronic hepatitis F4 at $22.99!!
A bottle of Chronic hepatitis F4 at $22.99!!
A month supply of Chronic hepatitis F4 at $79.99!! Save over $10.00!
A month supply of Chronic hepatitis F4 at $79.99!! Save over $10.00!
12 bottles of  Chronic hepatitis F4 at $219.99!! Save almost $50.00!!
12 bottles of  Chronic hepatitis F4 at $219.99!! Save almost $50.00!!
Disclaimer: Please click here to view our disclaimer page before ordering. Thanks!

This page was last updated on: December 4, 2005